Managing ADT-Related Adverse Effects of Prostate Cancer

The presentation provides a comprehensive overview of ADT-related adverse effects and management strategies, grounded in clinical experience and evidence-based medicine. Dr. Rabow’s expertise in palliative care lends authority, and he effectively communicates complex information in an accessible manner. The categorization of side effects into cardiovascular, hormonal, and vitality domains is clear and practical. He appropriately emphasizes the importance of behavioral interventions, particularly physical activity and CBT, which are safe and have broad benefits. The inclusion of pharmacological options for specific symptoms adds practical value. However, the talk lacks specific citations or references to clinical trials, and some statistics (e.g., 20% excess cardiac morbidity) are presented without sources, which may limit verifiability. The discussion of cardiovascular risk is particularly important, as heart disease is a leading cause of death, and he correctly advocates for early assessment and coordination with cardiologists. The emphasis on shared decision-making and team-based care is commendable, aligning with patient-centered approaches. The title accurately reflects the content, and the talk is well-structured. Overall, it is a valuable resource for patients and caregivers, though it could benefit from more detailed evidence and references. The presence of a brief promotional segment for UCTV does not detract from the educational content.

The title accurately reflects the content, which focuses on managing adverse effects of ADT for prostate cancer.

8/10

The presentation is given by a palliative care physician with clinical expertise, referencing established medical knowledge and evidence-based interventions. It is part of a university conference, lending credibility. However, specific citations and data are not provided in detail, and some claims are generalized.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by Dr. Rabow, a palliative care physician, setting the stage for discussing ADT side effects.
• 01:00Overview of three main adverse effects: cardiovascular, hormonal, and vitality.
• 02:00Discussion on cardiovascular risks, including heart disease, hypertension, and stroke, and the role of cardio-oncology.
• 04:00Hormonal side effects: osteoporosis, muscle loss, breast enlargement, and hot flashes.
• 06:00Vitality issues: fatigue, sleep disturbance, low libido, and emotional changes including depression.
• 08:00Introduction to management strategies: behavioral interventions vs. medications.
• 09:00Physical activity as a key intervention: 150 minutes per week, benefits for fatigue, sexual function, and overall health.
• 12:00Cognitive behavioral therapy (CBT): principles, effectiveness for depression, fatigue, and sleep, and practical considerations.
• 15:00Pharmacological options for depression, hot flashes, fatigue, and sleep, including SSRIs, gabapentin, and melatonin.
• 17:00Emphasis on personalized, team-based care and shared decision-making with patients and clinicians.

• UCTV — Main platform for the video and related content.
• UCTV Health — Section of UCTV featuring health and medicine programs.
• Prostate Cancer Patient Conference — Conference series where this talk was presented.

• American Cancer Society - ADT side effects — Provides similar information on ADT side effects and management.